PRS23 Pharmacoeconomic Analysis of Roflumilast for Treatment of Adult Patients With Severe-to-Very Severe Chronic Obstructive Pulmonary Disease (COPD)
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.2022
https://www.valueinhealthjournal.com/article/S1098-3015(12)03735-7/fulltext
Title :
PRS23 Pharmacoeconomic Analysis of Roflumilast for Treatment of Adult Patients With Severe-to-Very Severe Chronic Obstructive Pulmonary Disease (COPD)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03735-7&doi=10.1016/j.jval.2012.08.2022
First page :
A563
Section Title :
Respiratory-Related Disorders
Open access? :
No
Section Order :
1508